WuXi Biologics (Cayman) I...

OTC: WXXWY · Real-Time Price · USD
7.99
0.29 (3.77%)
At close: Aug 15, 2025, 3:33 PM

WuXi Biologics (Cayman) Income Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
18.68B 17.03B 15.27B 10.29B
Cost of Revenue
11.02B 10.21B 8.54B 5.46B
Gross Profit
7.65B 6.83B 6.72B 4.83B
Operating Income
4.97B 4.45B 4.35B 3.17B
Interest Income
350.37M 219.18M 51.41M 58.03M
Pretax Income
4.83B 4.17B 5.36B 3.99B
Net Income
3.36B 3.4B 4.42B 3.39B
Selling & General & Admin
2.15B 1.79B 1.43B 1B
Research & Development
766.44M 785.82M 689.57M 507.83M
Other Expenses
-236.54M n/a 17.94M 837K
Operating Expenses
2.68B 2.38B 1.42B 854.61M
Interest Expense
157.59M 158.49M 64.38M 39.19M
Selling & Marketing Expenses
473.6M 294.01M 162.91M 124.65M
Cost & Expenses
13.7B 12.58B 9.96B 6.32B
Income Tax Expense
889.03M 603.18M 807.87M 484.54M
Shares Outstanding (Basic)
2.15B 2.08B 2.19B 2.2B
Shares Outstanding (Diluted)
2.13B 2.17B 2.19B 2.21B
EPS (Basic)
1.56 1.54 2.12 1.62
EPS (Diluted)
1.58 1.56 2.02 1.54
EBITDA
6.43B 5.5B 5.07B 3.62B
EBIT
4.99B 4.33B 4.35B 3.17B
Depreciation & Amortization
1.44B 1.17B 800.67M 481.78M